Switch to:
More From Other Websites
CytRx Announces Publication of Phase 1b/2 Aldoxorubicin Clinical Data in Soft Tissue Sarcoma in... Oct 20 2014
CytRx Announces Publication of Phase 1b/2 Aldoxorubicin Clinical Data in Soft Tissue Sarcoma in... Oct 20 2014
CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue... Oct 17 2014
CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue... Oct 17 2014
CytRx Appoints Steven A. Kriegsman as Chairman of the Board Oct 16 2014
CytRx Appoints Steven A. Kriegsman as Chairman of the Board Oct 16 2014
CytRx Launches Discovery Laboratory to Develop Albumin-Binding Anti-Cancer Drug Platform Oct 13 2014
CytRx Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin and Gemcitabine in... Oct 09 2014
CytRx Announces Unexpected Passing of Chairman Max Link, PhD Oct 07 2014
CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of... Sep 30 2014
CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of... Sep 29 2014
CytRx Updates Presentation Time at BioCentury's 2014 NewsMakers in the Biotech Industry Conference Sep 26 2014
CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase... Sep 22 2014
CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference Sep 19 2014
Federman & Sherwood Investigates CytRx Corporation for Possible Violations of Federal Securities... Sep 16 2014
Former Louisiana Attorney General and KSF Announce Appointment as Lead Counsel in CytRx Securities... Sep 15 2014
Zeldes & Haeggquist, LLP Continues Investigation of CytRx Corporation Sep 15 2014
CytRx Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin and Ifosfamide/Mesna as... Sep 09 2014
CytRx Updates Presentation Time at Aegis 2014 Healthcare & Technology Conference Sep 05 2014
CytRx to Present at Upcoming Investor Conferences in New York City and Las Vegas Sep 02 2014


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK